Scynexis (SCYX) EPS (Diluted) Growth (5y) (2018 - 2026)
Powered by 
Analysis
Scynexis (SCYX) EPS (Diluted) Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.17% |
| Mar 31, 2026 | -12.80% |
| Dec 31, 2025 | 16.13% |
| Sep 30, 2025 | -35.31% |
| Jun 30, 2025 | 26.32% |
| Mar 31, 2025 | 31.41% |
| Dec 31, 2024 | 14.95% |
| Sep 30, 2024 | 45.34% |
| Jun 30, 2024 | 30.11% |
| Mar 31, 2024 | 14.91% |
| Dec 31, 2023 | 18.27% |
| Sep 30, 2023 | 51.57% |
| Jun 30, 2023 | 25.04% |
| Mar 31, 2023 | 20.38% |
| Dec 31, 2022 | 44.84% |
| Sep 30, 2022 | 24.02% |
| Jun 30, 2022 | 35.43% |
| Mar 31, 2022 | 41.81% |
| Dec 31, 2021 | 21.39% |
| Sep 30, 2021 | 65.99% |